Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
20
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 37%
🔄 Reverse Split
model est. 65%
• 50-day avg $0.01 below $1 exchange minimum
• 10 months cash with weak price
💰 Capital Raise
model 15%
• Under 12 months cash (10mo)
Market Data
Market Cap$254.2K
Shares Outstanding42.37M
Float36.25M
Cash$3.49M
Debt$1.74M
Short InterestN/A
Institutional Holdings
10.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest754
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2020-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual PTPI Dilution Snapshot
Petros Pharmaceuticals, Inc. (PTPI) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for PTPI: xbrl on 2026-06-30; xbrl on 2020-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: